Corindus Vascular Robotics, Inc.
309 Waverley Oaks Road, Suite 105
Waltham, MA 02452
November 1, 2019
VIA EDGAR
Securities and Exchange Commission,
Division of Corporation Finance,
100 F Street, N.E.
Washington, D.C. 20549
Re: |
Corindus Vascular Robotics, Inc. Request for Withdrawal Pursuant to Rule 477 of Post-Effective Amendment to Registration Statement No. 333-176581 |
|
Ladies and Gentlemen:
In accordance with Rule 477 promulgated under the Securities Act of 1933, as amended, Corindus Vascular Robotics, Inc. (the “Company”) hereby requests the withdrawal of Post-Effective Amendment (the “Post-Effective Amendment”) to Registration Statement No. 333-176581, filed with the Securities and Exchange Commission on October 29, 2019 (Accession No. 0001387131-19-007964).
The Company requests withdrawal of the Post-Effective Amendment because it was inadvertently coded with an incorrect file number. The Company confirms that no securities have been issued or sold pursuant to the Post-Effective Amendment.
Thank you for your assistance with this matter. If you have any questions concerning this request, please contact the undersigned at 508-653-3335, extension 228.
Sincerely, | |
/s/ David W. Long | |
David W. Long | |
Chief Financial Officer |